1. A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114). Issue 9 (23rd March 2022) Authors: Sakashita, Hiroyuki; Uchibori, Ken; Jin, Yasuto; Tsutsui, Toshiharu; Honda, Takayuki; Sakakibara, Rie; Mitsumura, Takahiro; Nukui, Yoshihisa; Shirai, Tsuyoshi; Masuo, Masahiro; Suhara, Kozo; Furusawa, Haruhiko; Yamashita, Takaaki; Ohba, Takehiko; Saito, Kazuhito; Takagiwa, Jun; Miyashita, Yoshihi... Journal: Thoracic cancer Issue: Volume 13:Issue 9(2022) Page Start: 1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment. (June 2020) Authors: Tozuka, Takehiro; Kitazono, Satoru; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Yanagitani, Noriko; Horai, Takeshi; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto Journal: Lung cancer Issue: Volume 144(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients. (2020) Authors: Tozuka, Takehiro; Yanagitani, Noriko; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Uematsu, Shinya; Yoshizawa, Takahiro; Hasegawa, Tsukasa; Ariyasu, Ryo; Uchibori, Ken; Kitazono, Satoru; Seike, Masahiro; Gemma, Akihiko; Nishio, Makoto Journal: Cancer treatment and research communications Issue: Number 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients. Issue 10 (19th August 2019) Authors: Kitazono, Satoru; Sakai, Kazuko; Yanagitani, Noriko; Ariyasu, Ryo; Yoshizawa, Takahiro; Dotsu, Yosuke; Koyama, Junji; Saiki, Masafumi; Sonoda, Tomoaki; Nishikawa, Shingo; Uchibori, Ken; Horiike, Atsushi; Nishio, Kazuto; Nishio, Makoto Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib. Issue 6 (7th May 2021) Authors: Sakamoto, Hiroaki; Yanagitani, Noriko; Manabe, Ryo; Tsugitomi, Ryosuke; Ogusu, Shinsuke; Tozuka, Takehiro; Yoshida, Hiroshi; Amino, Yoshiaki; Ariyasu, Ryo; Uchibori, Ken; Kitazono, Satoru; Tasaka, Sadatomo; Nishio, Makoto Journal: Cancer reports Issue: Volume 4:Issue 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2. Issue 6 (2nd February 2021) Authors: Uchibori, Ken; Takano, Natsuki; Manabe, Ryo; Tsugitomi, Ryosuke; Ogusu, Shinsuke; Tozuka, Takehiro; Sakamoto, Hiroaki; Yoshida, Hiroshi; Amino, Yoshiaki; Ariyasu, Ryo; Kitazono, Satoru; Yanagitani, Noriko; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 12:Issue 6(2021) Page Start: 906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody. (July 2019) Authors: Saiki, Masafumi; Yoshizawa, Takahiro; Dotsu, Yosuke; Ariyasu, Ryo; Koyama, Junji; Sonoda, Tomoaki; Uchibori, Ken; Nishikawa, Shingo; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Nishio, Makoto Journal: Lung cancer Issue: Volume 133(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms. Issue 3 (8th February 2020) Authors: Yanagitani, Noriko; Uchibori, Ken; Koike, Sumie; Tsukahara, Mika; Kitazono, Satoru; Yoshizawa, Takahiro; Horiike, Atsushi; Ohyanagi, Fumiyoshi; Tambo, Yuichi; Nishikawa, Shingo; Fujita, Naoya; Katayama, Ryohei; Nishio, Makoto Journal: Cancer science Issue: Volume 111:Issue 3(2020) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice. Issue 4 (21st December 2020) Authors: Ariyasu, Ryo; Uchibori, Ken; Ninomiya, Hironori; Ogusu, Shinsuke; Tsugitomi, Ryosuke; Manabe, Ryo; Sakamaoto, Hiroaki; Tozuka, Takehiro; Yoshida, Hiroshi; Amino, Yoshiaki; Kitazono, Satoru; Yanagitani, Noriko; Takeuchi, Kengo; Nishio, Makoto Journal: Thoracic cancer Issue: Volume 12:Issue 4(2021) Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer. (March 2018) Authors: Ariyasu, Ryo; Nishikawa, Shingo; Uchibori, Ken; Oh-hara, Tomoko; Yoshizawa, Takahiro; Dotsu, Yosuke; Koyama, Junji; Saiki, Masafumi; Sonoda, Tomoaki; Kitazono, Satoru; Yanagitani, Noriko; Horiike, Atsushi; Inase, Naohiko; Kasahara, Kazuo; Nishio, Makoto; Katayama, Ryohei Journal: Lung cancer Issue: Volume 117(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗